Mr. Speaker, I listened attentively to my colleague from Oshawa. He mentioned something that I want to ensure I understood correctly.
He talked about the notion that the pharmaceutical industry felt that the inefficiencies related to getting their drug systems approved were costing it a lot of money, and the fact that it had to go through all these regions was a negative situation.
Is the member promoting a more reinforced Government of Canada national standards for these program approvals? Is that what I understood him to say?